Crescent Grove Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $891K | Buy |
36,595
+2,056
| +6% | +$50.1K | 0.09% | 122 |
|
|
2025
Q1 | $717K | Buy |
34,539
+4,030
| +13% | +$83.7K | 0.07% | 131 |
|
|
2024
Q4 | $718K | Buy |
30,509
+1,595
| +6% | +$37.6K | 0.07% | 133 |
|
|
2024
Q3 | $740K | Buy |
28,914
+460
| +2% | +$11.8K | 0.08% | 136 |
|
|
2024
Q2 | $668K | Buy |
28,454
+4,660
| +20% | +$109K | 0.07% | 139 |
|
|
2024
Q1 | $684K | Buy |
23,794
+2,009
| +9% | +$57.8K | 0.07% | 143 |
|
|
2023
Q4 | $715K | Sell |
21,785
-3
| -0% | -$98 | 0.08% | 138 |
|
|
2023
Q3 | $607K | Sell |
21,788
-274
| -1% | -$7.63K | 0.08% | 150 |
|
|
2023
Q2 | $752K | Sell |
22,062
-534
| -2% | -$18.2K | 0.08% | 129 |
|
|
2023
Q1 | $679K | Hold |
22,596
| – | – | 0.08% | 139 |
|
|
2022
Q4 | $638K | Sell |
22,596
-927
| -4% | -$26.2K | 0.07% | 153 |
|
|
2022
Q3 | $773K | Sell |
23,523
-161
| -0.7% | -$5.29K | 0.09% | 122 |
|
|
2022
Q2 | $746K | Buy |
23,684
+4,039
| +21% | +$127K | 0.08% | 128 |
|
|
2022
Q1 | $902K | Buy |
19,645
+860
| +5% | +$39.5K | 0.09% | 120 |
|
|
2021
Q4 | $1.15M | Sell |
18,785
-642
| -3% | -$39.3K | 0.11% | 102 |
|
|
2021
Q3 | $1.45M | Buy |
19,427
+1,916
| +11% | +$143K | 0.15% | 79 |
|
|
2021
Q2 | $1.62M | Sell |
17,511
-8,169
| -32% | -$756K | 0.17% | 70 |
|
|
2021
Q1 | $2.28M | Buy |
25,680
+17,094
| +199% | +$1.52M | 0.27% | 50 |
|
|
2020
Q4 | $801K | Buy |
8,586
+5,101
| +146% | +$476K | 0.1% | 83 |
|
|
2020
Q3 | $222K | Buy |
+3,485
| New | +$222K | 0.04% | 151 |
|